Senior Manager/Associate Director
Scholar Rock
Senior Manager/Associate Director
Scholar Rock
Biopharmaceutical firm targeting protein growth factors
Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.
As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
Reporting to the VP, Finance EMEA, the Senior Manager (SM)/ Associate Director (AD) Accounting will manage the monthly close process and ensure timelines are met. The SM/AD Accounting will serve as the primary coordinator for the monthly close across EMEA entities (CH, IE, DE, and future markets), partnering closely with the global accounting team in alignment with the company close calendar. The SM/AD Accounting will establish and maintain processes to ensure compliance with SOX and external reporting requirements.
The position requires the ability to excel in a rapidly evolving environment, analyze existing processes, and propose and implement improvements. The successful candidate will maintain a positive, collaborative attitude while staying well organized in a fast-paced, high-growth setting.
This role requires strong organization, clear communication, attention to detail, and a strong sense of teamwork, and will help build a critical function at a growing, evolving, multi-product biotechnology company.
Biopharmaceutical firm targeting protein growth factors
Scholar Rock develops biopharmaceutical therapies by targeting protein growth factors to treat diverse diseases. Its work hinges on a proprietary drug discovery platform that identifies ways to modulate these growth factors, enabling creation of novel therapeutic solutions. The company advances its programs through research and development, and collaborates with other biopharmaceutical companies and research institutions, earning revenue via licensing agreements, milestone payments, and eventual product sales. Scholar Rock differentiates itself by focusing on protein growth factors and pursuing targets and indications that have been historically overlooked, with a strong emphasis on partnerships and patient-centric approaches. The overall goal is to deliver safe and effective therapies that improve patient outcomes by precisely modulating growth factor pathways through collaborative science.
Explore more opportunities at Scholar Rock